© 2009 BMJ Publishing Group Ltd
Clinical and Molecular Characterization of Bardet–Biedl Syndrome in Consanguineous Populations: The Power of Homozygosity Mapping
1 KFSHRC, Saudi Arabia;
2 KKESH, Saudi Arabia
Correspondence to: , ; alkuraya{at}mobilyconnect.com.sa
Accepted 24 September 2009
Bardet–Biedl syndrome (BBS) is a ciliopathy with pleiotropic effect that manifests primarily as renal insufficiency, polydactyly, retinal dystrophy, and obesity. Current phenotype/genotype correlation is insufficient to predict the likely causative mutation which makes sequencing of all 14 BBS genes often necessary but highly complicated way to identify the underlying genetic defect in affected patients. In this study we show that homozygosity mapping is a robust approach that is highly suited for genetically heterogeneous autosomal recessive disorders in populations where consanguinity is prevalent. This approach allowed us to quickly identify seven novel mutations in seven families with BBS. Some of these mutations would have been missed by unguided routine sequencing which suggests that missed mutations in known BBS genes could be more common than previously thought. This study, the largest to date on Saudi BBS families, also revealed interesting phenotypic aspects of BBS including the first report of nonsyndromic retinitis pigmentosa as a novel BBS phenotype.
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
